Pharmaron Beijing: Profit Up, Dividend Hold

Pharmaron Beijing Co., Ltd. Class H (HK:3759) has released an update.

Pharmaron Beijing Co., Ltd. reports a slight revenue decrease of 0.6% in the first half of 2024, with a notable profit increase of 41.6% for owners of the parent company compared to the previous year. Despite the profit growth, the company experienced a 14.1% drop in net cash flow from operating activities and has decided not to issue an interim dividend for the period.

For further insights into HK:3759 stock, check out TipRanks’ Stock Analysis page.